Urbana, IL, United States of America

David C Park


Average Co-Inventor Count = 19.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):

Title: Innovations of David C Park

Introduction

David C Park is a notable inventor based in Urbana, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiangiogenic and anticancer properties. His work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

David C Park holds a patent for "Sulfonamides having antiangiogenic and anticancer activity." This patent describes compounds that inhibit methionine aminopeptidase-2 (MetAP2). Additionally, it outlines pharmaceutical compositions that include these compounds, methods for treating cancer, and techniques for inhibiting angiogenesis.

Career Highlights

David C Park is associated with Abbott Laboratories Corporation, a leading global healthcare company. His work at Abbott has allowed him to focus on innovative solutions in the pharmaceutical industry. His research and development efforts contribute to advancing medical science and improving therapeutic options for patients.

Collaborations

David has collaborated with notable colleagues, including Kenneth M Comess and Scott A Erickson. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

David C Park's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing cancer treatment. His work exemplifies the impact of dedicated inventors in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…